Ilika PLC CEO Graeme Purdy talked with Proactive about a significant milestone for the company as it successfully shipped its 10Ah Goliath battery prototypes on schedule. Purdy noted that the delivery reflects the company's commitment to meeting expectations and keeping to its timelines.
Shares in Ilika PLC (AIM:IKA, OTCQX:ILIKF) rose 4% to 44.2p after the solid-state battery developer began shipping its latest 10Ah Goliath prototypes, a step the company said keeps it on schedule for commercialisation. The new cells, aimed at customers across several industries, including automotive, offer five times the capacity of the 2Ah versions released in July 2024.
Ilika PLC (AIM:IKA, OTCQX:ILIKF), the solid-state battery specialist, has started sending out its latest Goliath prototypes, a step the company says puts it firmly on schedule as it works towards commercial production. The new 10Ah cells, which are heading to customers in several industries, including carmakers, carry five times the capacity of the 2Ah versions Ilika released in July 2024.
Ilika PLC (AIM:IKA, OTCQX:ILIKF) this week delivered a trading update that outlined the battery company's continued progress for both its Stereax and Goliath solid-state battery programmes. The company said it had reached the final stages of preparation for shipping Stereax batteries to its first customers.
Ilika PLC (AIM:IKA, OTCQX:ILIKF) provided a trading update for the six months to 31 October, reporting progress across its Stereax and Goliath solid-state battery programmes. The company, in a statement ahead of financial results to be released in January, confirmed its Stereax M300 micro-battery production line at Cirtec Medical's Massachusetts facility had completed process qualification.
Ilika PLC (AIM:IKA, OTCQX:ILIKF) has completed commissioning of its automated Goliath solid-state battery (SSB) pilot line, marking a key milestone toward commercialisation of its large-format battery technology. The 1.5MWh facility is now fully operational, enabling production of consistent, high-yield cells for customer validation and testing programmes.
Ilika PLC (AIM:IKA, OTCQX:ILIKF) this week outlined the objectives of its PRIMED programme, which is designed to accelerate progress on the company's Goliath solid-state battery roadmap. Chief executive Graeme Purdy joined the studio and told Proactive that the programme represents “a fantastic piece of support” to help Ilika deliver a key milestone of producing 50Ah A-Sample batteries.
Ilika PLC (AIM:IKA, OTCQX:ILIKF) this week announced the completion of process qualification for its Stereax M300 batteries in collaboration with Cirtec Medical. The milestone follows the commissioning of manufacturing equipment in January and successful production trials, and, Ilika told investors that the qualified process will now enable production of products for testing and initial customer deliveries, which are expected to commence by the end of the calendar year.
Ilika PLC (AIM:IKA, OTCQX:ILIKF) has started production of its solid-state micro-batteries in the United States after completing the final stage of qualification at a partner facility in Massachusetts. The AIM-listed company said its Stereax M300 line at Cirtec Medical's site in Lowell had passed technical checks, allowing manufacturing to move ahead for testing and first deliveries.
Ilika PLC (AIM:IKA, OTCQX:ILIKF) earlier this week shared progress on its Stereax and Goliath battery programs as part of its annual results, where CEO Graeme Purdy revealed that the company should be able to start recognising revenue from customer deliveries this year. The company said both the smaller Stereax and larger Goliath had achieved key milestones and that commercial activity remains on track for 2025.
Ilika PLC (AIM:IKA, OTCQX:ILIKF) looks to be heading for a turning point. After years of development work, the British battery innovator has started to bring in early commercial revenue and is now lining up what could be a big year in 2026.
Ilika PLC (AIM:IKA, OTCQX:ILIKF) hailed a year of important technical and commercial achievements in the development of its Stereax and Goliath solid-state battery technologies as it reported full-year results for the twelve months to 30 April. The period saw manufacturing of its Stereax miniature batteries transferred to US-based partner Cirtec Medical, with key equipment installed at a cleanroom facility in Massachusetts.